Ning Sun

Title: **Ning Sun: A Pioneer in Targeted Protein Degradation Innovation**

Introduction

Ning Sun, a notable inventor based in Shanghai, China, has made significant contributions to the field of pharmaceuticals, particularly in the area of targeted protein degradation. With a portfolio that includes four patents, his recent innovations focus on anti-tumor applications that employ advanced compound designs.

Latest Patents

Sun's latest patents include groundbreaking compounds that aim to degrade specific target proteins for anti-tumor uses. One of his key inventions is centered around a compound formula composed of three essential components: a small molecule compound (SMBP) that binds to a target protein, a linker (LIN), and a ubiquitin ligand (ULM). This designed series of compounds demonstrates a broad range of pharmacological activities, including the ability to degrade targeted proteins and inhibit their functions, which positions them as potential treatments for various tumors.

In another significant patent, he introduced an ALK protein degradation agent, which includes compounds that not only degrade ALK target proteins but also inhibit their activity. This innovation is structured around four components: ALK-TKI, a linker (LIN), a ubiquitin ligase binding moiety (ULM), and a carbonyl group. Collectively, these aspects highlight Ning Sun’s innovative approach to combatting tumors through targeted degradation mechanisms.

Career Highlights

Ning Sun has primarily worked at prominent organizations such as ShanghaiTech University and Sph No. 1 Biochemical & Pharmaceutical Co., Ltd. His engagement with these institutions has facilitated his research and development efforts in advancing pharmaceutical technologies, particularly in oncology.

Collaborations

Throughout his career, Ning Sun has collaborated with several professionals, including notable colleagues Xiaobao Yang and Biao Jiang. These collaborations have been instrumental in enhancing the scope and impact of his inventions in the biopharmaceutical industry.

Conclusion

Ning Sun's inventive journey illustrates a dedication to innovating within the therapeutic landscape of cancer treatment. His patents herald new possibilities for targeted therapies, specifically through protein degradation mechanisms. As the field of pharmaceutical inventions continues to evolve, Sun's contributions position him as a key figure in the ongoing battle against tumors.